150 related articles for article (PubMed ID: 30721061)
1. DDX3X Helicase Inhibitors as a New Strategy To Fight the West Nile Virus Infection.
Brai A; Martelli F; Riva V; Garbelli A; Fazi R; Zamperini C; Pollutri A; Falsitta L; Ronzini S; Maccari L; Maga G; Giannecchini S; Botta M
J Med Chem; 2019 Mar; 62(5):2333-2347. PubMed ID: 30721061
[TBL] [Abstract][Full Text] [Related]
2. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-
Eyer L; Fojtíková M; Nencka R; Rudolf I; Hubálek Z; Ruzek D
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642926
[TBL] [Abstract][Full Text] [Related]
3. Unique Domain for a Unique Target: Selective Inhibitors of Host Cell DDX3X to Fight Emerging Viruses.
Riva V; Garbelli A; Brai A; Casiraghi F; Fazi R; Trivisani CI; Boccuto A; Saladini F; Vicenti I; Martelli F; Zazzi M; Giannecchini S; Dreassi E; Botta M; Maga G
J Med Chem; 2020 Sep; 63(17):9876-9887. PubMed ID: 32787106
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X.
Brai A; Ronzini S; Riva V; Botta L; Zamperini C; Borgini M; Trivisani CI; Garbelli A; Pennisi C; Boccuto A; Saladini F; Zazzi M; Maga G; Botta M
Molecules; 2019 Nov; 24(21):. PubMed ID: 31690062
[TBL] [Abstract][Full Text] [Related]
5. Murine Efficacy and Pharmacokinetic Evaluation of the Flaviviral NS5 Capping Enzyme 2-Thioxothiazolidin-4-One Inhibitor BG-323.
Bullard KM; Gullberg RC; Soltani E; Steel JJ; Geiss BJ; Keenan SM
PLoS One; 2015; 10(6):e0130083. PubMed ID: 26075394
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication.
Blázquez AB; Vázquez-Calvo Á; Martín-Acebes MA; Saiz JC
Viruses; 2018 Feb; 10(2):. PubMed ID: 29473907
[TBL] [Abstract][Full Text] [Related]
7. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
Nelson J; Roe K; Orillo B; Shi PY; Verma S
Antiviral Res; 2015 Oct; 122():39-45. PubMed ID: 26225754
[TBL] [Abstract][Full Text] [Related]
9. Vector derived artificial miRNA mediated inhibition of West Nile virus replication and protein expression.
Karothia D; Kumar Dash P; Parida M; Bhagyawant SS; Kumar JS
Gene; 2020 Mar; 729():144300. PubMed ID: 31884102
[TBL] [Abstract][Full Text] [Related]
10. RK-33 Is a Broad-Spectrum Antiviral Agent That Targets DEAD-Box RNA Helicase DDX3X.
Yang SNY; Atkinson SC; Audsley MD; Heaton SM; Jans DA; Borg NA
Cells; 2020 Jan; 9(1):. PubMed ID: 31936642
[TBL] [Abstract][Full Text] [Related]
11. The in vitro and in vivo antiviral properties of combined monoterpene alcohols against West Nile virus infection.
Pliego Zamora A; Edmonds JH; Reynolds MJ; Khromykh AA; Ralph SJ
Virology; 2016 Aug; 495():18-32. PubMed ID: 27152479
[TBL] [Abstract][Full Text] [Related]
12. Identification of active antiviral compounds against a New York isolate of West Nile virus.
Morrey JD; Smee DF; Sidwell RW; Tseng C
Antiviral Res; 2002 Jul; 55(1):107-16. PubMed ID: 12076755
[TBL] [Abstract][Full Text] [Related]
13. West Nile Virus NS2B/NS3 protease as an antiviral target.
Chappell KJ; Stoermer MJ; Fairlie DP; Young PR
Curr Med Chem; 2008; 15(27):2771-84. PubMed ID: 18991636
[TBL] [Abstract][Full Text] [Related]
14. Sultam thiourea inhibition of West Nile virus.
Barklis E; Still A; Sabri MI; Hirsch AJ; Nikolich-Zugich J; Brien J; Dhenub TC; Scholz I; Alfadhli A
Antimicrob Agents Chemother; 2007 Jul; 51(7):2642-5. PubMed ID: 17452483
[TBL] [Abstract][Full Text] [Related]
15. Ribavirin inhibits West Nile virus replication and cytopathic effect in neural cells.
Jordan I; Briese T; Fischer N; Lau JY; Lipkin WI
J Infect Dis; 2000 Oct; 182(4):1214-7. PubMed ID: 10979920
[TBL] [Abstract][Full Text] [Related]
16. Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.
Jiménez de Oya N; Blázquez AB; Casas J; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712653
[TBL] [Abstract][Full Text] [Related]
17. New avenues for therapeutic discovery against West Nile virus.
Sinigaglia A; Peta E; Riccetti S; Barzon L
Expert Opin Drug Discov; 2020 Mar; 15(3):333-348. PubMed ID: 32017639
[No Abstract] [Full Text] [Related]
18. Modification of the Host Cell Lipid Metabolism Induced by Hypolipidemic Drugs Targeting the Acetyl Coenzyme A Carboxylase Impairs West Nile Virus Replication.
Merino-Ramos T; Vázquez-Calvo Á; Casas J; Sobrino F; Saiz JC; Martín-Acebes MA
Antimicrob Agents Chemother; 2016 Jan; 60(1):307-15. PubMed ID: 26503654
[TBL] [Abstract][Full Text] [Related]
19. West Nile virus in blood: stability, distribution, and susceptibility to PEN110 inactivation.
Mather T; Takeda T; Tassello J; Ohagen A; Serebryanik D; Kramer E; Brown F; Tesh R; Alford B; Chapman J; Lazo A
Transfusion; 2003 Aug; 43(8):1029-37. PubMed ID: 12869107
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection.
Jiménez de Oya N; San-Félix A; Casasampere M; Blázquez AB; Mingo-Casas P; Escribano-Romero E; Calvo-Pinilla E; Poderoso T; Casas J; Saiz JC; Pérez-Pérez MJ; Martín-Acebes MA
Antimicrob Agents Chemother; 2023 Apr; 67(4):e0168722. PubMed ID: 36920206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
